Using a Graft Arrival Time Estimation Formula Decreases Operation Time in Transplantation From Deceased Donor.

Background: Prolonged operation time is a risk factor for negative clinical outcomes in deceased donor transplantation. Implementing a graft arrival time estimation formula to facilitate communication among the transplantation team and to determine the start time for deceased donor liver transplantation (LT) or kidney transplantation (KT) may help reduce operation time.

Methods: This was a single-center retrospective study reviewing adult deceased donor LT or KT recipients.

Pulsed radiofrequency of lumbar dorsal root ganglion versus epidural neuroplasty for lumbar radicular pain: a systematic review and network meta-analysis.

Background: Lumbar radicular pain (LRP) and/or lower back pain is a challenging condition, particularly in cases refractory to conservative treatments like epidural steroid injections (ESI). Pulsed radiofrequency (PRF) to the dorsal root ganglion and epidural neuroplasty techniques are emerging as alternative interventional treatments. However, there are no direct comparison studies between PRF and epidural neuroplasty, leading to uncertainty in optimal treatment selection.

Postoperative liver injury after sevoflurane or propofol anesthesia in patients undergoing non-cardiac surgery: a retrospective cohort study.

Although sevoflurane is generally considered safe, reports suggest that sevoflurane may cause postoperative liver injury more frequently than previously believed. Therefore, we aimed to compare the incidence of clinically significant postoperative liver injury following non-cardiac surgery between patients who underwent sevoflurane anesthesia and propofol-based total intravenous anesthesia. We retrospectively reviewed adult surgical patients from January 2010 to September 2022 who underwent general anesthesia in our center using sevoflurane or propofol over 3 h.

The association of withholding or continuing angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers on acute kidney injury after non-cardiac surgery.

Background: Withholding or continuing angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers peri-operatively in non-cardiac surgery remains controversial as they may result in intra-operative hypotension and postoperative organ damage.

Methods: We included patients prescribed angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers who underwent surgical procedures > 1 h duration under general or spinal anaesthesia from January 2012 to June 2022 in a single centre. We categorised patients by whether these drugs were withheld for 24 h before surgery.

Evaluation of pulse oximeter at the nasal septum during general anesthesia: comparison with finger oximeter.

Purpose: Though the finger is generally recommended for pulse oxygen saturation (SpO) monitoring site, its reliability may be compromised in conditions of poor peripheral perfusion. Therefore, we compared the performance of nasal septum SpO monitoring with finger SpO monitoring relative to simultaneous arterial oxygen saturation (SaO) monitoring in generally anesthetized patients.

Methods: In 23 adult patients, comparisons of SpO measured at the nasal septum and finger with simultaneous SaO were made at four time points during the 90 min study period.

Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.

Study Objective: To evaluate the effect of continuing of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) prescriptions 24 h before surgery on postoperative myocardial injury and blood pressure in patients undergoing non-cardiac surgery.

Design: A single-center, retrospective study.

Setting: Operating room and perioperative care area.

Effects of Pravastatin on Type 1 Diabetic Rat Heart with or without Blood Glycemic Control.

Although statins have been suggested to attenuate the progression of diabetic cardiomyopathy, its effect without glycemic control remains unclear. Therefore, we evaluated the effect of pravastatin on diabetic rat hearts according to glycemic control. Rats were randomly divided into five groups: control (C), diabetes (D), diabetes with insulin (I), diabetes with pravastatin (P), and diabetes with insulin and pravastatin (IP).